Global TB Vaccines 麻豆原创 Research Report 2023

Publication ID:

PB503235685

Publication Date:

March 15, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Gu茅rin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
Highlights
The global TB Vaccines market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for TB Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for TB Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of TB Vaccines include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for TB Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TB Vaccines.
The TB Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global TB Vaccines market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TB Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
Segment by Type
Immunotherapeutic Vaccines
Booster Vaccines
Others
Segment by Application
Hospitals
Private Clinics
Research Institutes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of TB Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 TB Vaccines 麻豆原创 Overview
1.1 Product Overview and Scope of TB Vaccines
1.2 TB Vaccines Segment by Type
1.2.1 Global TB Vaccines 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Immunotherapeutic Vaccines
1.2.3 Booster Vaccines
1.2.4 Others
1.3 TB Vaccines Segment by Application
1.3.1 Global TB Vaccines 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Private Clinics
1.3.4 Research Institutes
1.4 Global TB Vaccines 麻豆原创 Size Estimates and Forecasts
1.4.1 Global TB Vaccines Revenue 2018-2029
1.4.2 Global TB Vaccines Sales 2018-2029
1.4.3 Global TB Vaccines 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 TB Vaccines 麻豆原创 Competition by Manufacturers
2.1 Global TB Vaccines Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global TB Vaccines Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global TB Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global TB Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of TB Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of TB Vaccines, Product Type & Application
2.7 TB Vaccines 麻豆原创 Competitive Situation and Trends
2.7.1 TB Vaccines 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest TB Vaccines Players 麻豆原创 Share by Revenue
2.7.3 Global TB Vaccines 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 TB Vaccines Retrospective 麻豆原创 Scenario by Region
3.1 Global TB Vaccines 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global TB Vaccines Global TB Vaccines Sales by Region: 2018-2029
3.2.1 Global TB Vaccines Sales by Region: 2018-2023
3.2.2 Global TB Vaccines Sales by Region: 2024-2029
3.3 Global TB Vaccines Global TB Vaccines Revenue by Region: 2018-2029
3.3.1 Global TB Vaccines Revenue by Region: 2018-2023
3.3.2 Global TB Vaccines Revenue by Region: 2024-2029
3.4 North America TB Vaccines 麻豆原创 Facts & Figures by Country
3.4.1 North America TB Vaccines 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America TB Vaccines Sales by Country (2018-2029)
3.4.3 North America TB Vaccines Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe TB Vaccines 麻豆原创 Facts & Figures by Country
3.5.1 Europe TB Vaccines 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe TB Vaccines Sales by Country (2018-2029)
3.5.3 Europe TB Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific TB Vaccines 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific TB Vaccines 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific TB Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific TB Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America TB Vaccines 麻豆原创 Facts & Figures by Country
3.7.1 Latin America TB Vaccines 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America TB Vaccines Sales by Country (2018-2029)
3.7.3 Latin America TB Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa TB Vaccines 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa TB Vaccines 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa TB Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa TB Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global TB Vaccines Sales by Type (2018-2029)
4.1.1 Global TB Vaccines Sales by Type (2018-2023)
4.1.2 Global TB Vaccines Sales by Type (2024-2029)
4.1.3 Global TB Vaccines Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global TB Vaccines Revenue by Type (2018-2029)
4.2.1 Global TB Vaccines Revenue by Type (2018-2023)
4.2.2 Global TB Vaccines Revenue by Type (2024-2029)
4.2.3 Global TB Vaccines Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global TB Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global TB Vaccines Sales by Application (2018-2029)
5.1.1 Global TB Vaccines Sales by Application (2018-2023)
5.1.2 Global TB Vaccines Sales by Application (2024-2029)
5.1.3 Global TB Vaccines Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global TB Vaccines Revenue by Application (2018-2029)
5.2.1 Global TB Vaccines Revenue by Application (2018-2023)
5.2.2 Global TB Vaccines Revenue by Application (2024-2029)
5.2.3 Global TB Vaccines Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global TB Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck & Co.,Inc
6.1.1 Merck & Co.,Inc Corporation Information
6.1.2 Merck & Co.,Inc Description and Business Overview
6.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck & Co.,Inc TB Vaccines Product Portfolio
6.1.5 Merck & Co.,Inc Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Pasteur TB Vaccines Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Laboratory
6.3.1 Japan BCG Laboratory Corporation Information
6.3.2 Japan BCG Laboratory Description and Business Overview
6.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Japan BCG Laboratory TB Vaccines Product Portfolio
6.3.5 Japan BCG Laboratory Recent Developments/Updates
6.4 China National Biotec Group
6.4.1 China National Biotec Group Corporation Information
6.4.2 China National Biotec Group Description and Business Overview
6.4.3 China National Biotec Group TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 China National Biotec Group TB Vaccines Product Portfolio
6.4.5 China National Biotec Group Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Serum Institute TB Vaccines Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 India Pvt. Ltd
6.6.1 India Pvt. Ltd Corporation Information
6.6.2 India Pvt. Ltd Description and Business Overview
6.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 India Pvt. Ltd TB Vaccines Product Portfolio
6.6.5 India Pvt. Ltd Recent Developments/Updates
6.7 InterVax Ltd
6.6.1 InterVax Ltd Corporation Information
6.6.2 InterVax Ltd Description and Business Overview
6.6.3 InterVax Ltd TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 InterVax Ltd TB Vaccines Product Portfolio
6.7.5 InterVax Ltd Recent Developments/Updates
6.8 GreenSignal
6.8.1 GreenSignal Corporation Information
6.8.2 GreenSignal Description and Business Overview
6.8.3 GreenSignal TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 GreenSignal TB Vaccines Product Portfolio
6.8.5 GreenSignal Recent Developments/Updates
6.9 Bio Pharma Limited
6.9.1 Bio Pharma Limited Corporation Information
6.9.2 Bio Pharma Limited Description and Business Overview
6.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bio Pharma Limited TB Vaccines Product Portfolio
6.9.5 Bio Pharma Limited Recent Developments/Updates
6.10 Statens Serum Institut
6.10.1 Statens Serum Institut Corporation Information
6.10.2 Statens Serum Institut Description and Business Overview
6.10.3 Statens Serum Institut TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Statens Serum Institut TB Vaccines Product Portfolio
6.10.5 Statens Serum Institut Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 TB Vaccines Industry Chain Analysis
7.2 TB Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 TB Vaccines Production Mode & Process
7.4 TB Vaccines Sales and 麻豆原创ing
7.4.1 TB Vaccines Sales Channels
7.4.2 TB Vaccines Distributors
7.5 TB Vaccines Customers
8 TB Vaccines 麻豆原创 Dynamics
8.1 TB Vaccines Industry Trends
8.2 TB Vaccines 麻豆原创 Drivers
8.3 TB Vaccines 麻豆原创 Challenges
8.4 TB Vaccines 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.